Safety and efficacy of chemotherapy in older adults with locally advanced and metastatic pancreatic ductal adenocarcinoma (PDAC)

被引：0
|
作者：
Ostios-Garcia, Lorena
Saade, Patricia
Grossman, Joseph Elan
Lanniello, Leanne
Bullock, Andrea J.
机构：
[1] Beth Israel Deaconess Med Ctr, Hematol Oncol Div, Boston, MA 02215 USA
[2] Brigham & Womens Hosp, Dept Med, Pulm & Crit Care, 75 Francis St, Boston, MA 02115 USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
654
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of combination chemotherapy regimens in older adults with pancreatic ductal adenocarcinoma: a systematic review
    Saade-Lemus, Patricia
    Biller, Leah
    Bullock, Andrea
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (06) : 2591 - 2599
  • [2] Platinum-based chemotherapy in locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): summary of evidence and application in clinical practice
    Reinacher-Schick, Anke
    Arnold, Dirk
    Venerito, Marino
    Goekkurt, Eray
    Kraeft, Anna-Lena
    Seufferlein, Thomas
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (12) : 752 - 763
  • [3] FOLFIRINOX for locally advanced and metastatic pancreatic ductal adenocarcinoma
    Hisai, Hiroyuki
    Tamaki, Sakurai
    Yuuki, Ikeda
    Yutaka, Koshiba
    Masafumi, Sato
    Ryosuke, Kawasaki
    Hiroshi, Gyobu
    Etsu, Miyazaki
    Tasuku, Hirako
    Shogo, Miura
    ANNALS OF ONCOLOGY, 2015, 26 : 120 - 120
  • [4] A Survival Model in Locally Advanced and Metastatic Pancreatic Ductal Adenocarcinoma
    Wang, Yi
    Xiao, Xiuying
    Wang, Tianyi
    Li, Lin
    Zhu, Yue
    Xu, Haiyan
    Chu, Yuening
    Jiao, Feng
    Cui, Jiujie
    Wang, Liwei
    JOURNAL OF CANCER, 2018, 9 (07): : 1301 - 1307
  • [5] Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe
    Javed, Muhammad Ahsan
    Beyer, Georg
    Le, Nha
    Vinci, Alessio
    Wong, Helen
    Palmer, Daniel
    Morgan, Robert D.
    Lamarca, Angela
    Hubner, Richard A.
    Valle, Juan W.
    Alam, Salma
    Chowdhury, Sumsur
    Ma, Yuk Ting
    Archibugi, Livia
    Capurso, Gabriele
    Maisonneuve, Patrick
    Neesse, Albrecht
    Sund, Malin
    Schober, Marvin
    Krug, Sebastian
    PANCREATOLOGY, 2019, 19 (01) : 97 - 104
  • [6] Efficacy and safety of KN046 plus nab-paclitaxel/gemcitabine as first-line treatment for unresectable locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC).
    Jin, Gang
    Guo, Shiwei
    Zhang, Yanqiao
    Ma, Yue
    Guo, Xiaodong
    Zhou, Xiaocui
    Yu, Qin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC)
    Babiker, Hani M.
    Karass, Michael
    Recio-Boiles, Alejandro
    Chandana, Sreenivasa R.
    McBride, Ali
    Mahadevan, Daruka
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (07) : 583 - 592
  • [8] Characterization of primary and metastatic pancreatic tumors in pancreatic ductal adenocarcinoma (PDAC)
    Martinez-Muniz, Andres E.
    Sivanand, Sharanya
    Vander Heiden, Matthew
    CANCER RESEARCH, 2019, 79 (13)
  • [9] Comprehensive genomic analysis in metastatic pancreatic ductal adenocarcinoma (PDAC).
    Wong, Hui-Li
    Jones, Martin
    Eirew, Peter
    Karasinska, Joanna
    Schrader, Kasmintan A.
    Lim, Howard John
    Shen, Yaoqing
    Jones, Steven
    Yip, Stephen
    Laskin, Janessa J.
    Marra, Marco
    Schaeffer, David F.
    Renouf, Daniel John
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [10] Efficacy of olaparib therapy in metastatic pancreatic ductal adenocarcinoma (PDAC) with homologous recombination deficiency (HRD).
    Tan, Elaine
    Hicks, James Kevin
    Blue, Kirsten
    Kim, Richard D.
    Carballido, Estrella M.
    Kim, Dae Won
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345